01 Identity
Registration and reporting
- Registration status
- Registered
- Reporting status
- Submission Received Late
- Charity type
- CIO
- Registered
- 2 July 2024
- Removed
- Not supplied
- Financial period
- 2 July 2024 – 4 April 2025
- Latest income
- £99,941
- Latest expenditure
- £15,436
- Owns or uses land
- No
- In administration
- No
- Insolvent
- No
- CIO
- Yes
Public contact address: The Noah Jordan Foundation, Unit 55 Clear Space, Dunveth Business Park, West Hill, Wadebridge, Cornwall, PL27 7FE
Website recorded by the regulator: www.tnjf.org.uk (displayed as text)
02 Activities
What the charity does
We fund research with the aim of improving clinical management, developing treatments, and finding a cure for rare, terminal paediatric mitochondrial diseases, such as Alpers-Huttenlocher Syndrome. We raise awareness among the public and healthcare professionals through events and training and support affected families with information, services, resources, and financial aid.
03 Official extract
Charity Annual Return History
- Fin Period Start Date
- 2 July 2024
- Fin Period End Date
- 4 April 2025
- Ar Cycle Reference
- AR25
- Reporting Due Date
- 4 February 2026
- Date Annual Return Received
- 10 February 2026
- Date Accounts Received
- 10 February 2026
- Total Gross Income
- £99,941
- Total Gross Expenditure
- £15,436
04 Official extract
Charity Annual Return Parta
- Latest Fin Period Submitted Ind
- Yes
- Fin Period Order Number
- 1
- Ar Cycle Reference
- AR25
- Fin Period Start Date
- 2 July 2024
- Fin Period End Date
- 4 April 2025
- Ar Due Date
- 4 February 2026
- Ar Received Date
- 10 February 2026
- Total Gross Income
- £99,941
- Total Gross Expenditure
- £15,436
- Grant Making Is Main Activity
- No
- Count Govt Contracts
- 0
- Count Govt Grants
- £0
- Charity Has Trading Subsidiary
- No
- Does Trustee Receive Any Benefit
- No
- Trustee Payments Acting As Trustee
- No
- Trustee Receives Payments Services
- No
- Trustee Receives Other Benefit
- No
- Trustee Resigned Employment
- No
- Count Volunteers
- 5
05 Official extract
Charity Area Of Operation
- Geographic Area Type
- Region
- Geographic Area Description
- Throughout England
- Welsh Ind
- No
06 Official extract
Charity Classification
- Classification Code
- 307
- Classification Type
- How
- Classification Description
- Provides Advocacy/advice/information
- Classification Code
- 101
- Classification Type
- What
- Classification Description
- General Charitable Purposes
- Classification Code
- 205
- Classification Type
- Who
- Classification Description
- Other Charities Or Voluntary Bodies
- Classification Code
- 103
- Classification Type
- What
- Classification Description
- The Advancement Of Health Or Saving Of Lives
- Classification Code
- 308
- Classification Type
- How
- Classification Description
- Sponsors Or Undertakes Research
- Classification Code
- 104
- Classification Type
- What
- Classification Description
- Disability
- Classification Code
- 102
- Classification Type
- What
- Classification Description
- Education/training
- Classification Code
- 201
- Classification Type
- Who
- Classification Description
- Children/young People
- Classification Code
- 302
- Classification Type
- How
- Classification Description
- Makes Grants To Organisations
- Classification Code
- 207
- Classification Type
- Who
- Classification Description
- The General Public/mankind
- Classification Code
- 301
- Classification Type
- How
- Classification Description
- Makes Grants To Individuals
07 Official extract
Charity Event History
- Charity Name
- THE NOAH JORDAN FOUNDATION
- Charity Event Order
- 1
- Event Type
- CIO registration
- Date Of Event
- 2024-07-02T00:00:00
08 Official extract
Charity Governing Document
- Governing Document Description
- CIO - FOUNDATION Registered 02 Jul 2024
- Charitable Objects
- THE OBJECT OF THE CIO IS: FOR THE PUBLIC BENEFIT TO RELIEVE SICKNESS AND PRESERVE AND PROTECT THE PHYSICAL AND MENTAL HEALTH OF SUFFERERS OF LIFE LIMITING PAEDIATRIC MITOCHONDRIAL DISEASE, IN PARTICULAR BUT NOT EXCLUSIVELY POLG RELATED MITOCHONDRIAL DISORDERS INCLUDING ALPERS HUTTENLOCHER SYNDROME, AND THEIR FAMILIES AND CARERS BY ALL OR ANY OF THE FOLLOWING MEANS:(1) THE PROVISION OF GRANTS TO PROMOTE MEDICAL RESEARCH INTO PAEDIATRIC MITOCHONDRIAL DISEASE, THE USEFUL RESULTS OF WHICH WILL BE PUBLISHED, WITH THE AIM OF FINDING A CURE AND MEDICATION TO ASSIST IN TREATMENT AND MANAGEMENT OF THE CONDITION; (2) RAISING AWARENESS ABOUT ALL AND ANY ISSUES RELATED TO PAEDIATRIC MITOCHONDRIAL DISEASE AMONG THE PUBLIC AND HEALTHCARE PROFESSIONALS;(3) PROVIDING FAMILIES LIVING WITH PAEDIATRIC MITOCHONDRIAL DISEASE WITH SERVICES, ITEMS, INFORMATION AND SUPPORT, INCLUDING FINANCIAL SUPPORT WHERE POSSIBLE.